Ignite Creation Date:
2024-05-19 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06418087
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2022-08-11
Brief Title:
Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma LCNEC
Sponsor:
Gruppo Oncologico Italiano di Ricerca Clinica
Organization:
Gruppo Oncologico Italiano di Ricerca Clinica
Organization Data
Organization:
Gruppo Oncologico Italiano di Ricerca Clinica
Class:
OTHER
Study ID:
DUPLE- GOIRC- 05-2020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Gruppo Oncologico Italiano di Ricerca Clinica
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None